Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nitric Oxide
100%
Endometriosis
100%
Statin Therapy
100%
Microvascular Function
100%
Vasodilation
27%
Cardiovascular Risk
18%
Atorvastatin
18%
Statins
18%
Endothelium-dependent Vasodilation
18%
Laser Doppler Flux
18%
Perfusion
9%
Adjunctive Therapy
9%
L-NAME
9%
Microdialysis
9%
Dose-response Curve
9%
Healthy Controls
9%
Acetylcholine
9%
Cutaneous Vascular Conductance
9%
Cardiovascular Disease
9%
Intervention Strategies
9%
Endothelial Dysfunction
9%
Sodium Nitroprusside
9%
Endothelial Function
9%
Systemic Inflammation
9%
Initial Manifestation
9%
Healthy Women
9%
Intradermal Microdialysis
9%
Nitric Oxide Synthase Inhibitors
9%
Anti-inflammatory Effect
9%
Endothelium-dependent
9%
HMG-CoA Reductase Inhibitors
9%
Impaired Endothelial Function
9%
Atorvastatin Treatment
9%
Medicine and Dentistry
Endometriosis
100%
Nitric Oxide
100%
Statin
100%
Vasodilatation
45%
Cardiovascular Disease
27%
Endothelial Function
27%
Atorvastatin
27%
Adjuvant Therapy
9%
Endothelial Dysfunction
9%
Dose Response
9%
Acetylcholine
9%
Sodium Nitroprusside
9%
Antiinflammatory Activity
9%
Nitric Oxide Synthase Inhibitor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
Statin (Protein)
100%
Endometriosis
100%
Atorvastatin
27%
Cardiovascular Disease
27%
Microdialysis
18%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
18%
Acetylcholine
9%
Inflammation
9%
Nitroprusside Sodium
9%
Antiinflammatory Activity
9%
Endothelial Dysfunction
9%
Nitric Oxide Synthase Inhibitor
9%